Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance by Frohner, Ingrid E et al.
Candida albicans cell surface superoxide dismutases
degrade host-derived reactive oxygen species to escape
innate immune surveillance
Ingrid E. Frohner, Christelle Bourgeois,
Kristina Yatsyk, Olivia Majer and Karl Kuchler*
Medical University Vienna, Christian Doppler Laboratory
for Infection Biology, Max F. Perutz Laboratories,
Campus Vienna Biocenter; A-1030 Vienna, Austria.
Summary
Mammalian innate immune cells produce reactive
oxygen species (ROS) in the oxidative burst reaction
to destroy invading microbial pathogens. Using quan-
titative real-time ROS assays, we show here that both
yeast and ﬁlamentous forms of the opportunistic
human fungal pathogen Candida albicans trigger
ROS production in primary innate immune cells
such as macrophages and dendritic cells. Through a
reverse genetic approach, we demonstrate that coc-
ulture of macrophages or myeloid dendritic cells with
C. albicans cells lacking the superoxide dismutase
(SOD) Sod5 leads to massive extracellular ROS accu-
mulation in vitro. ROS accumulation was further
increased in coculture with fungal cells devoid of
both Sod4 and Sod5. Survival experiments show that
C. albicans mutants lacking Sod5 and Sod4 exhibit a
severe loss of viability in the presence of macroph-
ages in vitro. The reduced viability of sod5D/D and
sod4D/D sod5D/D mutants relative to wild type is not
evident with macrophages from gp91phox -/- mice
defective in the oxidative burst activity, demonstrat-
ing a ROS-dependent killing activity of macrophages
targeting fungal pathogens. These data show a physi-
ological role for cell surface SODs in detoxifying ROS,
and suggest a mechanism whereby C. albicans, and
perhaps many other microbial pathogens, can evade
host immune surveillance in vivo.
Introduction
Invasive Candida albicans infections are life-threatening
clinical conditions affecting immunosuppressed patients
and those with general defects in the immune system. The
mortalities associated with disseminated candidiasis can
be as high as 30–40%, despite extensive antifungal thera-
pies (Pfaller and Diekema, 2007). Host defences against
fungi range from non-speciﬁc proteolytic defences to dedi-
cated adaptive immune responses (Romani, 2004; Netea
et al., 2008). The earliest host response to fungal patho-
gens, including C. albicans, relies on fungal recognition
by innate immune cells such as dendritic cells, macroph-
ages and neutrophils and involves pattern recognition
receptors, followed by the subsequent phagocytosis and
elimination of microbial pathogens (Brown and Gordon,
2005; Akira et al., 2006; Jouault et al., 2006; Taylor, 2007;
Gow et al., 2007).
Upon interaction with pathogens, phagocytes rapidly
produce reactive oxygen species (ROS), which are
thought to aid killing of invading microbes (Dinauer, 1993;
Morgenstern et al., 1997), and further activate defensive
signalling pathways reviewed in Forman and Torres
(2002) and Netea et al. (2008). ROS production is initi-
ated through assembly and activation of nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase in
phagocytes (Babior, 2004). This triggers the respiratory
burst by generating superoxide anions (O2
-) (Schrenzel
et al., 1998), which are subsequently converted to hydro-
gen peroxide (H2O2), hydroxyl radical (OH°) and
hypochlorous acid, the latter conversion only taking place
in neutrophils.
In C. albicans, the Cat1 catalase has been implicated in
counteracting the respiratory burst by protecting cells
from killing by H2O2 stress. Cells lacking Cat1 also display
attenuated virulence in an invasive mouse virulence
model as reviewed in Chauhan et al. (2006). Furthermore,
the C. albicans genome harbours six genes encoding
putative superoxide dismutases (SOD), four of which are
copper-zinc (CuZn)-dependent, namely the cytoplasmic
Sod1 and the cell surface Sod4, Sod5 and Sod6; two
SODs, the mitochondrial Sod2 and cytoplasmic Sod3, are
manganese-dependent (Chauhan et al., 2006). SODs
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- into molecular oxygen and hydrogen perox-
ide, thereby scavenging the toxic effects of O2
- and pre-
venting higher H2O2 levels by other downstream reactions
(Teixeira et al., 1998).
The best-studied C. albicans SODs with respect to their
role in pathogenesis are Sod1 and Sod5, the latter being
a GPI-anchored cell surface protein (Fradin et al., 2005).
Both appear required for virulence of C. albicans in inva-
sive mouse models (Hwang et al., 2002). Further, fungal
cells lacking Sod1 are sensitive to menadione and more
sensitive to killing by macrophages than a wild-type strain
(Hwang et al., 2002). SOD5 is upregulated under osmotic
and oxidative stress conditions, as well as during yeast-
to-hyphae transition (Martchenko et al., 2004). Moreover,
transcriptional proﬁling indicates that SOD5 expression is
also upregulated by neutrophil contact, in presence of
neutrophils and viability of a sod5D/D mutant is reduced
relative to the wild type. Notably, both Sod4 and Sod6 are
predicted GPI-anchored cell wall proteins reviewed in
Richard and Plaine (2007), but their function has not been
analysed. The surface location of Sod4, Sod5 and Sod6
prompted the notion that they may protect C. albicans
against extracellular stress (Fradin et al., 2005; Gantner
et al., 2005).
In this work, we demonstrate a pivotal role for
C. albicans SODs in destroying host-derived ROS. We
show that primary innate immune cells rapidly respond to
fungal pathogens by mounting a protective ROS response
to destroy invading cells. We exploit a reverse genetic
approach to show that certain C. albicans SODs counter-
act the respiratory burst. Strikingly, we demonstrate that
Sod5, and to a lesser extent Sod4, catalyses destruction
of host-derived ROS. Interestingly, sod5D/D and sod4D/D
sod5D/D C. albicans show decreased viability in the pres-
ence of macrophages. Thus, our data identify SOD5 as a
novel C. albicans gene, mediating detoxiﬁcation of host-
derived ROS. The results suggest a molecular mecha-
nism whereby fungal pathogens can escape the
immediate early immune response, namely the oxidative
burst reaction.
Results
C. albicans yeast and hyphae forms trigger ROS in
macrophages and dendritic cells
The earliest response of innate immune cells facing patho-
gens includes the production of ROS (DeLeo et al., 1999;
Forman and Torres, 2002). Thus, we asked whether C. al-
bicans can induce ROS in mouse bone marrow-derived
macrophages (BMDMs) as well as myeloid dendritic cells
(mDCs). To investigate production of total ROS, we
adapted a luminol-dependent, chemiluminescence assay
in the presence of horseradish peroxidase (HRP). Oxida-
tion of luminol by ROS leads to chemiluminescence and
the luminescence measured is proportional to the ROS
produced in the system (Dahlgren and Karlsson, 1999).
In order to determine the optimal ratio of C. albicans to
host immune cells, we ﬁrst performed experiments with
different multiplicities of infection (MOI). Yeast forms of
the clinical isolate C. albicans SC5314 induced ROS in
BMDMs and mDCs at an MOI ranging from 2:1 (fungi to
macrophages) up to 10:1 (Fig. 1A a and b). No ROS were
detected with an MOI of 20:1 and higher (data not shown).
The optimal ROS response by BMDMs and mDCs was
observed with a 5:1 MOI (Fig. 1A). Notably, the oxidative
burst of mDCs is more than ﬁve times higher than that of
BMDMs (Fig. 1A c). Zymosan, a crude cell wall prepara-
tion from Saccharomyces cerevisiae, served as positive
control in all experiments (Gantner et al., 2003). Mature
hyphal forms of C. albicans (up to 12 mg per well dry
weight equivalent) also induced ROS in BMDMs (Fig. 1B).
To determine whether ROS are produced by immune cells
or fungi, we used BMDMs differentiated from gp91phox -/-
mice lacking an essential NADPH subunit required for
ROS production. As expected, no ROS production was
observed when gp91phox -/- BMDMs were incubated with
zymosan. A substantially blunted signal was detected
when C. albicans interacted with gp91phox -/- BMDMs
(Fig. 1C). Thus, these data demonstrate that both yeast
and hyphal forms of C. albicans can trigger ROS produc-
tion in BMDMs as well as mDCs. Importantly, ROS
detected by the assays is mainly derived from mammalian
immune cells, as gp91phox -/- BMDMs failed to generate
ROS.
ROS accumulate when sod5D/D cells infect BMDMs
Like most organisms, fungi possess various antioxidant
enzymes to counteract oxidative damage, including
thioredoxin, glutathione reductase, catalase, gluthathione
peroxidase as well as SODs. The genome of C. albicans
encodes six putative SODs (SOD1–6, reviewed in
Chauhan et al., 2006).
To clarify which C. albicans SODs are involved in
the response to innate immune cells, we constructed
homozygous deletion strains, each lacking one of the six
C. albicans SOD genes (SOD1–6) in the SN152 genetic
background (Noble and Johnson, 2005). To create a HIS1
LEU2 prototrophic control strain, we integrated the
CdLEU2 and CmHIS1 cassettes at their corresponding
genomic loci in the SN152 strain, yielding the strain
CA-IF100, hereafter referred to as wild type throughout
the text. This wild-type strain induced ROS to levels
similar to the clinical isolate SC5314, suggesting that the
different genetic backgrounds or auxotrophic markers did
not affect ROS release (data not shown). We then tested
the phenotypes of mutants lacking SODs concerning
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ing intracellular superoxide radicals, and diamide, a
thiol-speciﬁc oxidant that can readily oxidize reduced
glutathione. We conﬁrmed the previously reported sensi-
tivities of C. albicans strains lacking SOD1 and SOD2 to
menadione, as well as the resistance to diamide, on SD
media (Hwang et al., 2002; 2003) (data not shown).
Importantly, the absence of extracellular SODs failed to
show any sensitivity or resistance to any of the drugs
causing intracellular oxidative stress, implying a putative
function in extracelluar ROS detoxiﬁcation.
Next, we tested phenotypes of cells lacking various
SODs concerning the activation of ROS production in
macrophages or dendritic cells using the luminol assay.
The interaction of primary BMDMs with C. albicans
sod1D/D or sod4D/D strains did not show any signiﬁcant
changes in ROS levels over a period of 90 min when
compared with the wild-type strain CA-IF100 (Fig. 2A a).
Similarly, the sod2D/D, sod3D/D and sod6D/D homozygous
deletion strains did not show any different ROS produc-
tion (data not shown). By contrast, ROS accumulated
more than fourfold when BMDMs were infected with the
sod5D/D deletion strain CA-IF019, but not with the sod5D/
SOD5 heterozygous strain (Fig. 2A a–c). As a control, we
also re-integrated a functional SOD5 gene into the corre-
sponding genomic locus, sod5D/D::SOD5 to construct the
revertant strain CA-IF070. As expected, ROS levels
induced by this strain were similar to those elicited by the
wild-type strain. The phorbol ester PMA, a potent ROS
inducer, was used as a positive control (Fig. 2A b). Similar
results were obtained for ROS induction by mutant and
wild-type strain using primary mDCs (Fig. 2B a and b).
Furthermore, no ROS accumulation was observed in
BMDMs derived from gp91phox -/- mice infected with
sod5D/D homozygous deletion strains and the wild-type
strain, unequivocally demonstrating that ROS accumula-
tion in BMDMs and mDCs requires functional gp91phox
and the absence of Sod5 (Fig. 2C), suggesting a role for
Sod5 in counteracting the oxidative burst of innate
immune cells in vitro.
Fig. 1. C. albicans induces ROS production in wild-type BMDMs and mDCs.
A–C. ROS measurement by luminol-dependent chemiluminescence at 37°C in 2.5 min intervals over a 90 min period [relative luciferase units
(RLU) min
-1 per 1000 immune cells].
A. Stimulation of BMDMs (a) or mDCs (b) with yeast-form C. albicans (yC.a) at an MOI of 2:1 (equivalent to 2 mg yeast dry weight per well),
5:1 (5 mg/well) or 10:1 (10 mg/well) or with zymosan (20 mg/well). (c) Quantiﬁcation of the total ROS release between 10 and 50 min
(striped area) by calculating the area under the curve (MOI 5:1). The average of three independent experiments is presented. *mDCs produce
5.5  0.35 times more ROS than BMDMs. **P < 0.02.
B. Stimulation of BMDMs with hyphae-form C. albicans (hC.a) at 3 mg dry weight/well, 6 mg/well or 12 mg/well.
C. Stimulation of gp91phox
-/- and wt BMDMs with yeast-form C. albicans at an MOI of 5:1 or zymosan (20 mg/well).
A–C. Results of one experiment per condition are shown. Data were reproduced in at least three independent experiments. Statistical
signiﬁcance was calculated using a two-tailed Student’s t-test.
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extracellular superoxide levels
The SODs are believed to destroy harmful superoxides
produced by converting them ﬁrst to H2O2; subsequently
catalase converts H2O2 into harmless H2O and O2.W e
therefore hypothesized that deletion of an SOD gene
should increase superoxide levels. Because the main
type of ROS detected by the luminol assay is peroxide but
not superoxide, we measured superoxide levels using
lucigenin as a luminescence probe (Li et al., 1998).
Superoxide accumulation in BMDMs cocultured with
the wild-type strain, as well as the sod4D/D strain, was
similar. By contrast, the sod5D/D mutant showed a more
than threefold superoxide accumulation. As expected,
superoxide accumulation was not observed in BMDMs
cocultured with the functionally restored sod5D/D::SOD5
strain (Fig. 3A).
The NADPH-oxidase is believed to assemble either in
the plasma membrane or in membranes of phagosomes
(Hampton et al., 1998; Kobayashi et al., 1998). Therefore,
ROS will either be released from cells or retained inside
the phagosomes. To discriminate the locations of ROS
accumulation, we measured ROS using isoluminol as a
luminescence probe (Lundqvist and Dahlgren, 1996),
which, in contrast to luminol, is membrane-impermeable.
In BMDMs, ROS accumulated about 10-fold higher in the
presence of sod5D/D cells, when compared with macro-
phages coincubated with sod6D/D cells or the wild-type
strain (Fig. 3B).
Fig. 2. ROS accumulate when BMDMs or mDCs, but not gp91phox
-/- BMDMs, are infected with sod5D/D cells.
A–C. ROS measurement by luminol-dependent chemiluminescence at 37°C in 2.5 min intervals over a 90 min period [relative luciferase units
(RLU) min
-1 per 1000 immune cells].
A. (a) Stimulation of BMDMs with either the wild type (CA-IF100) strain or the sod1D/D (CA-IF003), sod4D/D (CA-IF015), sod5D/D (CA-IF019)
mutant strains or sod5D/SOD5 heterozygous strain (CA-IF017) (MOI 5:1). (b) Stimulation of BMDMs with the sod5D/D::SOD5 revertant
(CA-IF027) (MOI 5:1) or PMA (10 nM). (c) Quantiﬁcation of the total ROS release between 10 and 60 min (striped area) by calculating the
area under the curve (MOI 5:1). The average of three independent experiments is presented. *Infection with sod5D/D yields 4.3  0.68 times
more ROS than with wild-type C. albicans. **P < 0.02.
B. (a) Stimulation of mDCs with either the wild type (CA-IF100) strain, or the sod1D/D (CA-IF003), sod4D/D (CA-IF015), sod6D/D (CA-IF023) or
sod5D/D mutant strains. (b) Quantiﬁcation of the total ROS release between 10 and 60 min (striped area) by calculating the area under the
curve. The average of three independent experiments is presented. *Infection with sod5D/D yields 4  0.64 times more ROS than with wild
type cells. **P < 0.05.
C. Stimulation of gp91phox
-/- or wild-type BMDMs with either the wild-type (CA-IF100) strain, the sod5D/D (CA-IF019) mutant strain or
sod5D/D::SOD5 re-integrant (CA-IF027).
A–C. Results of one experiment per condition are shown. Data were reproduced in at least three independent experiments. Statistical
signiﬁcances were calculated using a two-tailed Student’s t-test.
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pre-loaded BMDMs with the non-ﬂuorescent dye H2DCF-
DA, which cannot cross cellular compartments after
esterase cleavage. Upon oxidation by ROS, H2DCF-DA
is converted to the ﬂuorescent product 2′-7′-
dichloroﬂuorescein (DCF). A limited permeability of DCF
retains it preferentially at the site where it was generated
(Yeung et al., 2005). Therefore, ROS produced in the
phagosomes is not detected by H2DCF-DA. We then
measured the generation of ROS after 15 min (Fig. 3C a)
and 45 min (Fig. 3C b) using the standard 5:1 MOI of
fungal cells to BMDMs and the phorbol ester PMA as a
control (Fig. 3C). FACS analysis showed that intracellular
ROS levels were induced at very similar levels by both
sod5D/D and the wild-type strains (Fig. 3C, violet overlay).
We conclude that Sod5 is involved in the detoxiﬁcation of
extracellular or phagosomal superoxides produced by
BMDMs, but has no effect on the intracellular ROS levels.
Fig. 3. Extracellular ROS accumulate in the presence of sod5D/D cells.
A. Superoxides measurement by lucigenin-dependent chemiluminescence at 37°C over a 90 min period [relative luciferase units (RLU) under
the curve]. Stimulation of BMDMs with either the wild-type (CA-IF100) strain, or the sod4D/D (CA-IF015), sod5D/D (CA-IF019) mutant strain or
the sod5D/D::SOD5 revertant (CA-IF027) (MOI 5:1). *Infection with sod5D/D yields 3.2  0.21 times more superoxides than with wild-type
C. albicans **P > 0.005.
B. Extracellular ROS measurement by isoluminol-dependent chemiluminescence at 37°C in 2.5 min intervals over a 90 min period [relative
luciferase units (RLU) min
-1 per 1000 cells]. Stimulation of BMDMs with either the wild-type (CA-IF100) strain or the sod5D/D (CA-IF019) or
sod6D/D (CA-IF023) mutant strains (MOI 5:1). Quantiﬁcation of the total ROS release between 30 and 70 min (striped area) by calculating the
area under the curve. *Infection with sod5D/D yields 10  0.5 times more extracellular ROS than with wild-type cells. **P > 0.001.
C. Intracellular ROS production in response to the phorbol ester PMA, wild-type (CA-IF100) strain or sod5D/D (CA-IF019) mutant strain was
measured by FACS analysis using H2DCF-DA staining of BMDMs after 15 min (a) or 40 min (b) of infection.
A–C. Results of one experiment per condition are shown. All data were reproduced in at least three independent experiments. Statistical
signiﬁcances were calculated using a two-tailed Student’s t-test.
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A previous report showed that SOD4 is upregulated in a
sod5D/D mutant cocultured with blood cells (Fradin et al.,
2005), suggesting that the lack of the SOD5 gene may
result in compensatory upregulation of other functionally
overlapping SOD genes. Northern analysis demonstrated
that SOD4 mRNA levels in yeast-form C. albicans were
lower than those of SOD5. However, both transcripts were
strongly upregulated under conditions promoting hyphal
transition, including higher temperature at 37°C or 37°C
plus serum (Fig. 4A). While we failed to detect SOD6-
speciﬁc expression via Northern analysis, we used qPCR
to detect SOD6 mRNAin the wild type, the single sod5D/D
mutant, as well as in the sod4D/D sod5D/D double deletion
strain, all of which were growing at 30°C and 37°C plus
Fig. 4. A sod4D/D deletion in a sod5D/D background boosts ROS accumulation.
A. Northern analysis of SOD4, SOD5 and ACT1 mRNA. The clinical C. albicans SC5314 strain was grown at 30°C, 37°C and 37°C plus 10%
FCS.
B. ROS measurement by luminol-dependent chemiluminescence at 37°C in 2.5 min intervals over a 90 min period [relative luciferase units
(RLU) min
-1 per 1000 BMDMs]. Stimulation of BMDMs with either the wild-type (CA-IF100) strain or sod5D/D (CA-IF019), sod5D/D::SOD5
(CA-IF027), sod4D/D sod5D/D (CA-IF039) and sod4D/D sod5D/D sod6D/D (CA-IF070) mutant strains (MOI 5:1) (a). Quantiﬁcation of the total
ROS release between 10 and 50 min (striped area) by calculating the area under the curve (MOI 5:1) and calculating the fold differences.
The average of four independent experiments is presented. Infection with sod4D/D sod5D/D yields 1.36  0.18 times more ROS than by a
sod5D/D strain. *P < 0.05, sod4D/D sod5D/D sod6D/D triple mutant yields 1.43  0.09 times more ROS than by a sod5D/D strain. *P < 0.02; and
the sod4D/D sod5D/D sod6D/D triple mutant yields 1.09  0.1 times more ROS than sod4D/D sod5D/D. ***P > 0.09 (b).
C. Superoxides measurement by lucigenin-dependent chemiluminescence at 37°C over a 90 min period [relative luciferase units (RLU) under
the curve]. Stimulation of BMDMs with either zymosan (20 mg/well), the wild-type (CA-IF100) strain, the sod5D/D (CA-IF019), sod4D/D sod5D/D
(CA-IF039) and sod4D/D sod5D/D sod6D/D (CA-IF070) mutant strains (MOI 5:1).
A and B. Results of one experiment per condition are shown. All data were reproduced in two independent experiments.
D. Intracellular ROS production in response to wild-type (CA-IF100) strain or sod4D/D (CA-IF015), sod4D/D sod5D/D (CA-IF039) mutant strains
(MOI 5:1) or zymosan (100 mgm l
-1). ROS was measured by FACS analysis using H2DCF-DA-staining of BMDMs after 45 min of infection.
A–C. Results of one experiment per condition are shown. All data were reproduced in at least three independent experiments. Statistical
signiﬁcances were calculated using a two-tailed Student’s t-test.
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under all conditions tested (data not shown), indicating
that SOD6 is not regulated during yeast to hyphae tran-
sition or by temperature. We therefore hypothesized that
SOD4 expression may compensate at least partially for
the lack of SOD5, while SOD6 is unable to do so. To test
this hypothesis, we generated sod4D/D sod5D/D and
sod4D/D sod6D/D double mutants and a sod4D/D sod5D/D
sod6D/D triple mutant (using the SAT1-ﬂipper cassette,
Reuss et al., 2004), and looked at ROS accumulation
after infecting BMDMs. When BMDMs were infected with
the sod4D/D sod5D/D double deletion strain, accumulation
of ROS was slightly (1.36 times), but signiﬁcantly higher
than in the presence of the respective sod5D/D single
deletion strain (Fig. 4B b). By contrast, a sod4D/D sod6D/D
double mutant strain did not affect the ROS accumulation
relative to single deletions or the wild-type cells (data not
shown). The sod4D/D sod5D/D sod6D/D triple mutant
slightly increased ROS accumulation when compared
with the sod4D/D sod5D/D double mutant, but without a
statistical signiﬁcance (Fig. 4B a + b). Superoxide accu-
mulation in BMDMs cocultured with the sod5D/D deletion
strain was again about threefold higher than with the
wild-type strain. BMDMs cocultured with the sod4D/D
sod5D/D double deletion accumulated about 1.5 times
more superoxides than the sod5D/D mutant strain. By
contrast, the sod4D/D sod5D/D sod6D/D triple deletion
strain showed no increase in superoxide accumulation
relative to the sod4D/D sod5D/D double mutant (Fig. 4C).
We then measured the generation of intracellular ROS
using the standard 5:1 MOI of fungal cells to BMDMs.
FACS analysis showed that after 30 min intracellular ROS
were induced at very similar levels by the sod4D/D,
sod4D/D sod5D/D mutant and the wild-type strains (data
not shown). Notably, after 45 min, the sod4D/D mutant
strain exhibited less intracellular ROS than the wild-type
control strain, but induced similar ROS levels as
zymosan; the sod4D/D sod5D/D mutant strains induced
levels of intracellular ROS similar to the wild type
(Fig. 4D).
Hence, these data suggest that Sod5 and Sod4 play a
major role in the clearance of ROS produced by innate
immune cells. Notably, Sod4, although present at very low
levels, can at least partially compensate for a loss of
Sod5.
Exogenous SOD rescues defects of cells lacking Sod4
and Sod5
Previous work indicated that a sod5D/D deletion strain
was attenuated in a mouse model for disseminated infec-
tion, and exhibited increased susceptibility to killing by
whole human blood cultures and polymorphonuclear neu-
trophils, but not to human monocytes or the macrophage
cell line RAW264.7 (Martchenko et al., 2004; Fradin et al.,
2005). Our data, as well as published virulence data,
predict that cells lacking SODs should display higher sus-
ceptibilities to killing by immune cells and thus exhibit
reduced viability in the presence of host cells. To examine
the contribution of all CuZn-dependent SOD mutants to
the defence of C. albicans against macrophage-derived
ROS, the wild-type, sod4D/D, sod5D/D in SN152, sod5D/
D::SOD5, sod4D/D sod5D/D, sod4D/D sod6D/D strains, the
clinical isolate SC5314 and a new sod5D/D mutant gen-
erated in the genetic background of the clinical isolate
SC5314 were tested for their viability in coculture with
primary BMDMs using a modiﬁed ‘endpoint dilution sur-
vival’ assay as described earlier (Rocha et al., 2001).
As shown in Fig. 5A, the quantiﬁcation of the survival
data of an interaction with BMDMs at the low MOI 1:1024
showed that 66.4% of the wild-type cells survived in the
presence of BMDMs. Likewise, sod4D/D, sod6D/D and
sod4D/D sod6D/D strains had very similar survival rates as
the wild type at all BMDM dilutions. As predicted, the
sod5D/D strain was hypersensitive to BMDM killing by
almost one order of magnitude, while the sod5D/D::SOD5
revertant displayed the same viability as the wild-type
control (Fig. 5A). When coculturing BMDMs with the
sod4D/D sod5D/D double mutant, viability was even
further reduced. The sod4D/D sod5D/D sod6D/D triple
mutant had a similar survival rate as the sod4D/D sod5D/D
double mutant (Fig. 5A a), demonstrating the functional
redundancy of at least Sod4 and Sod5. The increased
sensitivity of sod5D/D and sod4D/D sod5D/D strains was
observed in coincubations with BMDMs at the higher MOI
of 1:4 for sod5D/D and 1:1 for sod4D/D sod5D/D cells
respectively (data not shown). To reconﬁrm our ﬁndings,
we also tested sod5D/D in the SC5314 background strain.
When infected with BMDMs, sod5D/D SC5314 cells
showed similar survival as the unrelated sod5D/D deletion
strain CA-IF019 (Fig. 5A b).
To unequivocally demonstrate the role of SOD in medi-
ating survival in the presence of BMDMs, we spiked sur-
vival assays with 10 U commercial bovine erythrocyte
SOD enzyme. Strikingly, exogenous SOD fully rescued
the viability defect to both sod5D/D and sod4D/D sod5D/D
double mutants (Fig. 5A, white bars). Furthermore, ROS
accumulation was also suppressed by the exogenous
SOD activity when BMDMs were infected with strains
lacking Sod5 or both Sod5 and Sod4 (data not shown).
Finally, we also used gp91phox -/- BMDMs to test whether
the absence of ROS production can increase the survival
of sod5D/D and sod4D/D sod5D/D strains (Fig. 5B). As
expected, in the presence of gp91phox -/- BMDMs, both
sod5D/D and sod4D/D sod5D/D double mutants showed a
survival comparable to the wild-type control. The same
results were obtained with the independent sod5D/D
mutant and the wild-type SC5314, respectively, in
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increased killing of the sod5D/D and sod4D/D sod5D/D by
innate immune cells is caused by host-derived ROS.
Taken together, our data demonstrate an essential role
of C. albicans Sod5 in counteracting the host-derived
immune defence as mounted through ROS to evade host
immune response.
Based on our results, we propose that C. albicans can
escape host-generated oxidative burst (Fig. 6). Adhesion,
recognition and phagocytosis of fungal cells by innate
immune cells trigger an immediate and rapid assembly of
the ROS machinery at the cell surface or in the forming
phagosomal membrane, preceding phagocytosis and
persisting throughout phagosomal formation (Nauseef,
2004). Concomitantly, host temperature and adhesion
may enhance SOD4 and SOD5 expression, followed by
the elimination of extracellular and perhaps phagosomal
ROS produced by host cells. In our in vitro assay dur-
ing phagocytosis, substrate and enzyme may become
trapped in the phagosomes. Hence, ROS production may
also continue within the phagosomes. The SOD-mediated
decay of host-derived ROS perhaps facilitates intrapha-
gosomal survival of fungal cells, which would facilitate
killing of the host cells. Taken together, these data reveal
a physiological function of cell surface SODs in evading
immune surveillance, thereby facilitating invasion and ulti-
mately dissemination of fungal pathogens in the mamma-
lian host (Fig. 6).
Discussion
In this report, we show that yeast and hyphal forms of
C. albicans rapidly induce ROS in primary innate immune
cells such as macrophages and dendritic cells. We dem-
onstrate that the GPI-anchored Sod5 and Sod4 enzymes
act to degrade extracellular ROS produced by innate
immune cells. Strikingly, C. albicans strains lacking SODs
Sod4 and Sod5 fail to counteract the host-derived oxida-
tive burst and are thus hyper-susceptible to killing by
Fig. 5. sod5D/D and sod4D/D sod5D/D strains are hypersensitive
to killing by BMDMs.
A and B. Survival of C. albicans and isogenic mutant cells was
determined using the end-point dilution assay. Mean and standard
deviation of three independent experiments are presented.
A. Wild-type BMDMs in medium without (ﬁlled bars) or with 10 U
commercial erythrocyte SOD (white bar) were coincubated with
either wild-type (wt) C. albicans strain or strains lacking SOD4
(s4D), SOD5 (s5D blue), the restored SOD5 (s5DS5), SOD6 (s6D)
or strains lacking both SOD4 and SOD6 (s4/6D), SOD4 and SOD5
(s4/5D green) or lacking all three SOD4, SOD5 and SOD6 (s4/5/6
brown) (a), or with the clinical isolate SC5314 and the sod5D/D
mutant in the SC5314 background (SC5314 s5D blue) (b) for 48 h
at 37°C with 5% CO2.
B. gp91phox
-/- BMDMs were infected with the wild type (wt) or
strains lacking SOD4 (s4D), SOD5 (s5D blue), the restored SOD5
(s5DS5) or strains lacking both SOD4 and SOD5 (s4/5D green), the
clinical isolate SC5314 or the sod5D/D mutant in the SC5314
background (SC5314 s5D). The percentage of survival for each
strain was determined as follows (colonies in absence of BMDMs
versus colonies in presence of BMDMs ¥ 100).
Fig. 6. Model for Sod4 and Sod5-mediated protection against
respiratory burst. Upon contact with BMDMs and mDCs, Sod4 and
Sod5 anchored at the C. albicans (C.a) surface (left) degrade
superoxide anions (O2
-) to hydrogen peroxide (H2O2). The lack of
the Sod4 and Sod5 (right) causes ROS accumulation in the
medium and perhaps inside the phagosomes (phago), which
results in enhanced killing of C. albicans. Production of
mitochondrial ROS (Mit) is unaffected.
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surface SODs in the evasion of immune surveillance.
Yeast and hyphae forms of C. albicans induce ROS in
BMDMs and mDCs
The ROS induction is independent of morphology as both
yeast and ﬁlamentous forms of C. albicans trigger ROS in
BMDMs (Fig. 1A). Our data agree in principle with previ-
ous studies showing ROS production upon fungal recog-
nition (Gantner et al., 2005), but in contrast to this earlier
report, we found that hyphae also have the capacity to
trigger ROS in BMDMs (Fig. 1B a). This discrepancy may
be due to differences in experimental conditions. Notably,
the previous study used higher MOI than our study. In our
hands, increasing MOI to similar high levels failed to
trigger ROS during the interaction of both yeast and
hyphal forms with BMDMs (data not shown), suggesting
that higher amounts of C. albicans may kill or exceed the
macrophage defence capacity.
We observed about 5.5 times more ROS upon interac-
tion of C. albicans with mDCs when compared with
BMDMs, perhaps as a consequence of higher NADPH
oxidase activities in mDCs (Fig. 1A a). Consistent with this
notion, similar observations were made in mDC respond-
ing to the phorbol ester PMA (Savina et al., 2006), one of
the strongest ROS triggers known. We unequivocally
demonstrate that the majority of ROS produced in
response to C. albicans is produced through the NADPH
oxidase present in immune cells, as ROS release is
almost absent in gp91phox -/- cells lacking a functional
oxidase (Fig. 1C).
Host cells produce ROS in response to C. albicans,a s
well as fungal surface structures, although the molecular
identities of ligands triggering ROS signalling remain
unknown. Possible candidates include beta1–3 as well as
beta 1–6 glucans (Gantner et al., 2003; Rubin-Bejerano
et al., 2007). However, the use of appropriate knock-out
mice may allow to answer which pattern recognition
receptors contribute to ROS signalling or mediate
C. albicans uptake into host cells (Netea et al., 2008).
C. albicans Sod5 degrades extracellular ROS produced
by immune cells
Experiments using monocyte-derived dendritic cells from
human blood show that C. albicans inhibit PMA-induced
superoxide production. This inhibition increases with
increasing numbers of C. albicans cells, whereas heat-
killed C. albicans fails to do so (Donini et al., 2007). Based
on our work, we propose that C. albicans actively coun-
teracts the oxidative burst of immune cells by expressing
and inducing expression of cell surface SODs, which may
therefore be considered fungal defence genes (Fig. 6).
The GPI-anchored Sod5 and Sod4, as well as Sod6, have
only been described in C. albicans so far. However,
BlastP or tBlastN analysis identiﬁed at least one coding
sequence potentially encoding putative GPI-anchored
homologous of SOD4, SOD5 or SOD6 in other fungal
pathogens, including Candida dubliniensis, Candida
tropicalis, Candida parapsilosis, Candida guilliermondi,
Debraryomyces hanseii and Lodderomyces elongisporus
(data not shown). Hence, these pathogens may rely on
similar mechanisms to counteract host-derived oxidative
stress. Infecting BMDMs and mDCs with C. albicans
mutants lacking putative Sod enzymes shows that Sod5
can degrade extracellular and maybe phagosomal super-
oxides, but not intracellular, superoxides produced by
BMDMs and mDCs (Fig. 3 and 4). Thus, to the best of
our knowledge, this is the ﬁrst report that a fungal cell
surface SOD degrades extracellular ROS released by
host cells.
The ability of C. albicans to destroy ROS in vitro may
explain why despite its cytotoxic potential, macrophages
are poor in killing C. albicans. Notably, even if only a small
fraction of fungal cells survive and escape phagosomal
killing to grow within the host, the subsequent ﬁlament
formation will physically destroy the host cell (Mansour
and Levitz, 2002). Furthermore, we and others (Martch-
enko et al., 2004) show that elevated temperature, yeast-
to-hyphae transition (Fig. 4A), as well as conditions
mimicking the phagosome environment, strongly induce
SOD5. Similarly, contact with neutrophils strongly acti-
vates SOD5 transcription (Fradin et al., 2005). Thus,
SOD5 upregulation is perhaps part of the mechanism
whereby the pathogen defence machinery responds to
adverse host conditions.
The upregulation of SOD4 in a sod5D/D deletion strain
(Fradin et al., 2005) partially compensates for the loss of
Sod5, providing redundant function. Indeed, we show that
the putative extracellular Sod4 also contributes to ROS
degradation, although at much lower capacity (Fig. 4B and
C). Interestingly, microarray data and our own preliminary
results (data not shown) suggest that Sod4 is also upregu-
lated upon the transition from the white form to the opaque
form of C. albicans (Lan et al., 2002), implying that Sod4
may also play a prominent role in ROS degradation in
the opaque form. Opaque phase C. albicans cells, for
instance, are better colonizers of the skin and are also
believed to colonize the anaerobic gastrointestinal tract.
Hence, Sod4 could play a more prominent role in the
gastrointestinaltractorinskininfections.Bycontrast,white
cells are more prevalent in bloodstream infections (Kvaal
et al., 1999; Dumitru et al., 2007; Ramirez-Zavala et al.,
2008), providing selective advantages for the survival of
opaque versus white cells in different host niches.
Notably, we were unable to detect a role in ROS decay
for Sod6, the third C. albicans SOD predicted to reside at
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type, the sod5 single as well as the sod4 sod5 double
deletion strains in YPD 30°C or YPD + FCS 37°C (data
not shown). Furthermore, removal of SOD6 in the
sod4D/D or the sod4D/D sod5D/D deletion strains does not
play a role in ROS degradation in vitro, at least in the
interaction with primary BMDMs. In vivo experiments
using animal models might provide more details as to a
possible protective function of SOD6. Moreover, a surface
localization of Sod6 has not been demonstrated or
published. Therefore, the possibility remains that Sod6
may also reside in another cellular compartment, explain-
ing the lack of ROS recognition during host interaction.
Cells lacking Sod4 and Sod5 are hypersensitive to
killing by host ROS
Candida albicans strains lacking the SOD5 gene display
attenuated virulence in mice in vivo (Martchenko et al.,
2004), and contribute to a better survival of C. albicans
in neutrophils (Fradin et al., 2005). This is in agreement
with our in vitro survival experiments, showing that
sod5D/D mutant cells in two independent genetic back-
grounds show strongly reduced survival in BMDMs
when compared with the wild-type control strain, and
the genomically restored SOD5 revertant (Fig. 5A).
However, our results are not in agreement with a previ-
ous study, reporting similar survival degrees of the sod5
mutant when compared with the wild-type strain
(Martchenko et al., 2004). However, the previous study
used the macrophage cell line RAW264.7, whereas we
exploited primary macrophages, which are likely to
display a pathogen response reminiscent of the normal
host situation. Hence, the RAW264.7 tumour cells might
very well display a different signalling response to C. al-
bicans than unstimulated primary BMDMs. Further, the
‘immortalized’ tumour RAW264.7 cells in question stem
from different progenitors than our BMDMs, as they
were isolated from ascites and not from bone marrow.
Interestingly, a recent report indicates that C. albicans is
more susceptible when applying the end-point dilution
survival assays with RAW264.7 cells than with BMDMs
(Marcil et al., 2008).
Cells lacking Sod4 and Sod5 show signiﬁcantly
decreased survival when compared with the single
sod5D/D mutant, conﬁrming the importance of Sod4 activ-
ity and the functional redundancy with Sod5. Further,
complementing the defect with commercial SOD from
bovine erythrocytes restores the survival of mutant strains
to almost wild-type levels. (Fig. 5A, white bars). Moreover,
wild type, sod5D/D and sod4D/D sod5D/D strains are all
equally sensitive to killing by gp91phox -/- BMDMs defec-
tive in ROS release. The remaining 30–40% killing effi-
ciency of gp91phox -/- macrophages, as well as the
30–40% killing of wild-type C. albicans strains by wild-
type BMDMs, may be independent of the oxidative burst
and stem from other host defence mechanisms such as
acidiﬁcation of the phagolysosomes (Watanabe et al.,
1991).
Our results recall previous ﬁndings showing that extra-
cellular CuZn SODs of bacteria, for example SodC of
Mycobacterium tuberculosis and the periplasmic SodC
of Salmonella typhimurium confer improved survival in
macrophages by degrading extracellular superoxides (De
Groote et al., 1997; Piddington et al., 2001). Our current
working model suggests that C. albicans can eliminate
ROS produced in the extracellular space of the macroph-
ages and dendritic cells, including ROS produced during
phagosome formation within immune cells (Fig. 6).
Taken together, this work suggests that pathogens able
to develop high oxidative stress tolerance are also more
resistant to killing by immune cells. Therefore, scavenging
ROS produced by the NADPH oxidase reaction through
surface SODs may represent a physiological mechanism
driving virulence, invasion and efficient survival in the host.
The work also suggests a general mechanism whereby
C. albicans and other fungal pathogens evade the host
immune response and surveillance. Hence, inhibiting or
blocking the extracellular SOD enzymes of C. albicans
may be a novel therapeutic approach to combat systemic
fungal disease. For instance, speciﬁc inhibitors of SODs
may prove useful novel drugs to be used alone or in
combination with existing antifungals to interfere or block
dissemination of fungal pathogens in vivo.
Experimental procedures
Reagents, media and growth conditions
Luminol, Lucigenin, Isoluminol, HRP Type VI, PMA, SOD
from bovine erythrocytes and zymosan were obtained from
Sigma (St Louis, MO). FCS, HBSS, H2DCF-DA were from
Invitrogen Molecular Probes (Oregon). DMEM was pur-
chased from PAA (Vienna, Austria), anti-mouse antibodies
CD16/CD32, CD11b-FITC, CD11c-APC, F4/80-PE-Cy5 were
obtained from BD Bioscience (Mountain View, CA). Rich
medium (YPD) and synthetic complete were prepared essen-
tially as described (Kaiser et al., 1994). BMDM media are
composed of DMEM, 10% heat-inactivated FCS, 20%
L-conditioned medium. mDC media are composed of DMEM,
10% heat-inactivated FCS, 10% X-conditioned medium.
C. albicans strains were grown at 30°C in YPD medium over-
night, diluted to an OD600 = 0.2 the next morning, grown to the
logarithmic growth phase and used for the experiment unless
indicated otherwise. For the preparation of mature ﬁlaments,
an overnight culture of C. albicans was diluted 1:10 in
YPD + 10% FCS and grown at 37°C for 3–4 h. For experi-
ments requiring stimulation of macrophages with ﬁlaments,
an aliquot of each culture was pelleted and the dry weight
was determined by routine procedures. Aliquots of cultures
equalling the indicated dry weights of yeast or ﬁlaments were
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4 yeast cells corre-
spond to 1 mg dry weight.
Fungal strains and construction of C. albicans
deletion mutants
Candida albicans strains, primers and plasmids used in this
study are listed in Tables S1–S3 respectively. The laboratory
strain SN152 served as wild-type parental strain to construct
single deletion strains (SOD1 to SOD6) using the method
described elsewhere (Noble and Johnson, 2005). SN152 is a
leucine, histidine, arginine auxotroph derivative of the clinical
isolate SC5314 (Gillum et al., 1984). The sod5 deletion was
also generated in the SC5314 background. Multiple gene
deletion mutants, as well as the sod5D/D in the SC5314
background, were created using the recyclable ‘SAT1-
ﬂipping’ method (Reuss et al., 2004). Transformation was
achieved by electroporation (Reuss et al., 2004). For all
strains used in this study, correct genomic integration was
veriﬁed by PCR and Southern blotting.
Mouse strains and cell culture of innate immune cells
The 7- to 9-week-old C57BL/6 wild-type mice were used for
preparation of BMDMs and mDCs. Frozen bone marrow of 6-
to 8-week-old gp91phox
-/- C57BL/6 mice was kindly provided
by Kristina Erikson (George-Chandy et al., 2008). Bone
marrow was collected from mouse femurs, treated with
red blood lysis buffer (8.29 g l
-1 NH4CL, 1 g l
-1 KHCO3,
0.0372 g l
-1 EDTA, pH 7.2–7.4) and re-suspended either in
macrophage media to induce differentiation into BMDMs or
in mDC media to prepare mDC according to previously
described methods (Hume and Gordon, 1983; Inaba et al.,
1992). After 3 days in culture, fresh medium was added.
mDCs were used after 7–8 days in culture. After 7 days,
BMDMs cultures were split 1:3 and further cultured up to day
10. BMDMs were used between day 10 and day 13 of
differentiation. Cell surface markers of the mDCs and
BMDMs cell preparation were assessed by ﬂow cytometry
using a panel of marker antibodies. mDCs preparations were
negative for F4/80, a macrophage marker, positive for
CD11b, and at least 50–60% of the cells were CD11c+.I n
BMDMs cultures, 95% of the cells expressed CD11b and
F4/80 markers.
ROS assays
For the detection of total, extracellular and intracellular ROS,
chemiluminescense assays were performed using electron
acceptors with various characteristics; luminol- (reacts
weakly with O2
-, strongly with other ROS like H2O2, HRP-
dependent), isoluminol- (extracellular O2
-, HRP dependent)
and lucigenin- (O2
-) enhanced chemiluminescence assays
were performed as described before (Dahlgren and Karlsson,
1999). Brieﬂy, BMDMs were suspended in culture medium at
a density of 4 ¥ 10
5 cells ml
-1 and kept warm at 37°C in a
water bath for a maximum of 30 min. And 100 ml aliquots of
cell suspension were distributed in a 96-well luminometer
plate (Nunc, Roskilde, Denmark); 50 ml HBSS medium con-
taining PMA (10 nM) or zymosan (100 mgm l
-1) as positive
controls and C. albicans mutants at the indicated cell
numbers were added. Immediately after adding stimuli, 50 ml
HBSS containing either 200 mM luminol or 600 mM Isoluminol
and 16 U HRP, or 400 mM lucigenin were distributed into
each well. Chemiluminescence was measured at 2.5 min
intervals at 37°C with a multiplate reader Wallac VictorV
3
(PerkinElmer). Data are expressed as relative luciferase units
min
-1 per 1000 BMDM cells over time, or as total relative
luciferase units under curve within 90 min. Area under the
curve was calculated using the trapezoidal method. Statisti-
cal signiﬁcances were calculated using two-tailed Student’s
t-test from three wells per condition or from data of three
independent experiments.
Intracellular ROS was measured using H2DCFA-DA dye to
determine hydrogen peroxide production. BMDMs were sus-
pended in HBSS at 5 ¥ 10
6 cells ml
-1 approximately 30 min
before measurements. Just prior to the experiment, cells
were loaded with 5 mMH 2DCF-DA in HBSS for 20 min at
room temperature in the dark, and pelleted at 300 g for 7 min
at room temperature. After washing with PBS, cells were
carefully re-suspended in HBSS at a density of 5 ¥ 10
6
cells ml
-1. Aliquots of 5 ¥ 10
5 cells were stimulated with dif-
ferent agents in HBSS. C. albicans (MOI 5:1) zymosan
(1 mg ml
-1), PMA (200 nM) and incubated for 15–45 min
at 37°C. After an additional washing step, cells were
re-suspended in 400 ml PBS, 0.1% BSA on ice, followed by
FACS analysis with FL1-H.
RNA extraction and Northern analysis
Total yeast RNA was isolated by the hot phenol method and
quantiﬁed exactly as described elsewhere (Kren et al.,
2003). About 15 mg of total RNA per sample was separated
in a 1.4% agarose gel and transferred to nylon membranes
(Amersham, Buckinghamshire, UK). Northern blots were
hybridized with PCR-ampliﬁed probes, which were
32P-
dCTP-radiolabelled by using a MegaPrime labelling kit
(Amersham) using conditions recommended by the manu-
facturer. Hybridization with puriﬁed probes was performed
exactly as previously described (Kren et al., 2003). Mem-
branes were washed three times in 2¥ SSC-1% SDS and
three times in 1¥ SSC-1% SDS at 65°C, and then exposed
to X-ray ﬁlms at -70°C. DNA probes for Northern blots were
PCR-ampliﬁed from genomic DNA using primers listed in
Table S1.
End-point dilution survival assays
End-point dilution survival assays were performed as
described previously (Rocha et al., 2001) with the following
modiﬁcations. BMDMs were seeded 1 day before the experi-
ment at 1 ¥ 10
5 cells per well in every second column of
ﬂat-bottom 96-well plates (Greiner, Longwood, Florida) in
BMDM medium. Next day, cells were washed twice with PBS
and 100 ml DMEM without phenol red containing 10% FCS.
Overnight cultures of C. albicans cells were washed in PBS,
and re-suspended at 2 ¥ 10
6 cells ml
-1 DMEM without phenol
red but with 10% FCS.Aliquots of 50 ml cell suspensions were
added to the ﬁrst two columns, and serial fourfold dilutions of
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Plates were spun at 500 g for 1 min, followed by incubation at
37°C and 5% CO2 for 48 h. Yeast colonies were stained in the
96-well plate with Cristal violet, using a 0.2% solution in 20%
MeOH exactly as described previously (Stockinger et al.,
2002). Viable colonies were counted and compared with
equivalent dilutions in wells with macrophages. An assay
setup of four to eight plates per day was deﬁned as one
experiment. At least three independent experiments were
performed per condition. Colonies from a total of at least 25
wells per condition were used to quantify viability data.
Acknowledgements
We thank all laboratory fellows and Bernhard Hube for critical
and helpful discussions. We are very grateful to K. Eriksson
for the gift of bone marrow from gp91phox
-/- knock-out mice,
Alexander Johnson for providing the SN152 strain, pSN52
and pSN40 plasmids and J. Morschhäuser for providing
the pSFS2A plasmid. C. albicans sequence data were
obtained from the Stanford Genome Center (http://www.
candidagenome.org). This work was supported by a grant
from the Christian Doppler Research Society to K.K., and in
part by a grant from the Vienna Science and Technology
Fund WWTF (Project HOPI-LS133). I.E.F. was supported
through the Vienna Biocenter PhD Programme WK001.
References
Akira, S., Uematsu, S., and Takeuchi, O. (2006) Pathogen
recognition and innate immunity. Cell 124: 783–801.
Babior, B.M. (2004) NADPH oxidase. Curr Opin Immunol 16:
42–47.
Brown, G.D., and Gordon, S. (2005) Immune recognition of
fungal [beta]-glucans. Cell Microbiol 7: 471–479.
Chauhan, N., Latge, J.P., and Calderone, R. (2006) Signal-
ling and oxidant adaptation in Candida albicans and
Aspergillus fumigatus. Nat Rev Microbiol 4: 435–444.
Dahlgren, C., and Karlsson, A. (1999) Respiratory burst in
human neutrophils. J Immunol Meth 232: 3–14.
De Groote, M.A., Ochsner, U.A., Shiloh, M.U., Nathan, C.,
McCord, J.M., Dinauer, M.C., et al. (1997) Periplasmic
superoxide dismutase protects Salmonella from products
of phagocyte NADPH-oxidase and nitric oxide synthase.
Proc Natl Acad Sci USA 94: 13997–14001.
DeLeo, F., Allen, L., Apicella, M., and Nauseef, W. (1999)
NADPH oxidase activation and assembly during
phagocytosis. J Immunol 163: 6732–6740.
Dinauer, M.C. (1993) The respiratory burst oxidase and the
molecular genetics of chronic granulomatous disease. Crit
Rev Clin Lab Sci 30: 329–369.
Donini, M., Zenaro, E., Tamassia, N., and Dusi, S. (2007)
NADPH oxidase of human dendritic cells: role in Candida
albicans killing and regulation by interferons, dectin-1 and
CD206. Eur J Immunol 37: 1194–1203.
Dumitru, R., Navarathna, D.H., Semighini, C.P., Elowsky,
C.G., Dumitru, R.V., Dignard, D., et al. (2007) In vivo and in
vitro anaerobic mating in Candida albicans. Eukaryot Cell
6: 465–472.
Forman, H.J., and Torres, M. (2002) Reactive oxygen species
and cell signaling: respiratory burst in macrophage
signaling. Am J Respir Crit Care Med 166: S4–S8.
Fradin, C., De Groot, P., MacCallum, D., Schaller, M., Klis, F.,
Odds, F.C., and Hube, B. (2005) Granulocytes govern the
transcriptional response, morphology and proliferation of
Candida albicans in human blood. Mol Microbiol 56: 397–
415.
Gantner, B.N., Simmons, R.M., Canavera, S.J., Akira, S., and
Underhill, D.M. (2003) Collaborative induction of inﬂamma-
tory responses by dectin-1 and Toll-like receptor 2. J Exp
Med 197: 1107–1117.
Gantner, B.N., Simmons, R.M., and Underhill, D.M. (2005)
Dectin-1 mediates macrophage recognition of Candida
albicans yeast but not ﬁlaments. Embo J 24: 1277–1286.
George-Chandy, A., Nordstrom, I., Nygren, E., Jonsson, I.M.,
Postigo, J., Collins, L.V., and Eriksson, K. (2008) Th17
development and autoimmune arthritis in the absence of
reactive oxygen species. Eur J Immunol 38: 1118–1126.
Gillum, A.M., Tsay, E.Y., and Kirsch, D.R. (1984) Isolation of
the Candida albicans gene for orotidine-5′-phosphate
decarboxylase by complementation of S. cerevisiae ura3
and E. coli pyrF mutations. Mol Gen Genet 198: 179–182.
Gow, N.A., Netea, M.G., Munro, C.A., Ferwerda, G., Bates,
S., Mora-Montes, H.M., et al. (2007) Immune recognition of
Candida albicans beta-glucan by dectin-1. J Infect Dis 196:
1565–1571.
Hampton, M.B., Kettle, A.J., and Winterbourn, C.C. (1998)
Inside the neutrophil phagosome: oxidants, myeloperoxi-
dase, and bacterial killing. Blood 92: 3007–3017.
Hume, D.A., and Gordon, S. (1983) Optimal conditions for
proliferation of bone marrow-derived mouse macrophages
in culture: the roles of CSF-1, serum, Ca2+, and
adherence. J Cell Physiol 117: 189–194.
Hwang, C.S., Rhie, G.E., Oh, J.H., Huh, W.K., Yim, H.S., and
Kang, S.O. (2002) Copper- and zinc-containing superoxide
dismutase (Cu/ZnSOD) is required for the protection of
Candida albicans against oxidative stresses and the
expression of its full virulence. Microbiology 148: 3705–
3713.
Hwang, C.S., Baek, Y.U., Yim, H.S., and Kang, S.O. (2003)
Protective roles of mitochondrial manganese-containing
superoxide dismutase against various stresses in Candida
albicans. Yeast 20: 929–941.
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M.,
Ikehara, S., et al. (1992) Generation of large numbers of
dendritic cells from mouse bone marrow cultures supple-
mented with granulocyte/macrophage colony-stimulating
factor. J Exp Med 176: 1693–1702.
Jouault, T., El Abed-El Behi, M., Martinez-Esparza, M.,
Breuilh, L., Trinel, P.A., Chamaillard, M., et al. (2006) Spe-
ciﬁc recognition of Candida albicans by macrophages
requires galectin-3 to discriminate Saccharomyces cerevi-
siae and needs association with TLR2 for signaling.
J Immunol 177: 4679–4687.
Kaiser, C., Michaelis, S., and Mitchell, A. (1994) Methods in
Yeast Genetics: A Laboratory Course Manual. New York,
NY: Cold Spring Harbor Laboratory Press.
Kobayashi, T., Robinson, J.M., and Seguchi, H. (1998) Iden-
tiﬁcation of intracellular sites of superoxide production in
stimulated neutrophils. J Cell Sci 111: 81–91.
C.albicans and oxidative burst of innate immune cells 251
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 71, 240–252Kren, A., Mamnun, Y.M., Bauer, B.E., Schuller, C., Wolfger,
H., Hatzixanthis, K., et al. (2003) War1p, a novel transcrip-
tion factor controlling weak acid stress response in yeast.
Mol Cell Biol 23: 1775–1785.
Kvaal, C., Lachke, S.A., Srikantha, T., Daniels, K., McCoy, J.,
and Soll, D.R. (1999) Misexpression of the opaque-phase-
speciﬁc gene PEP1 (SAP1) in the white phase of Candida
albicans confers increased virulence in a mouse model of
cutaneous infection. Infect Immun 67: 6652–6662.
Lan, C.Y., Newport, G., Murillo, L.A., Jones, T., Scherer, S.,
Davis, R.W., and Agabian, N. (2002) Metabolic specializa-
tion associated with phenotypic switching in Candida
albicans. Proc Natl Acad Sci USA 99: 14907–14912. Epub
12002 October 14923.
Li, Y., Zhu, H., Kuppusamy, P., Roubaud, V., Zweier, J.L.,
and Trush, M.A. (1998) Validation of lucigenin (bis-N-
methylacridinium) as a chemilumigenic probe for detecting
superoxide anion radical production by enzymatic and cel-
lular systems. J Biol Chem 273: 2015–2023.
Lundqvist, H., and Dahlgren, C. (1996) Isoluminol-enhanced
chemiluminescence: a sensitive method to study the
release of superoxide anion from human neutrophils. Free
Radic Biol Med 20: 785–792.
Mansour, M.K., and Levitz, S.M. (2002) Interactions of fungi
with phagocytes. Curr Opin Microbiol 5: 359–365.
Marcil, A., Gadoury, C., Ash, J., Zhang, J., Nantel, A., and
Whiteway, M. (2008) Analysis of PRA1 and its relationship
to Candida albicans- macrophage interactions. Infect
Immun 76: 4345–4358.
Martchenko, M., Alarco, A.M., Harcus, D., and Whiteway, M.
(2004) Superoxide dismutases in Candida albicans: tran-
scriptional regulation and functional characterization of the
hyphal-induced SOD5 gene. Mol Biol Cell 15: 456–467.
Morgenstern, D.E., Gifford, M.A., Li, L.L., Doerschuk, C.M.,
and Dinauer, M.C. (1997) Absence of respiratory burst in
X-linked chronic granulomatous disease mice leads to
abnormalities in both host defense and inﬂammatory
response to Aspersillus fumigatus. J Exp Med 185: 207–
218.
Nauseef, W.M. (2004) Assembly of the phagocyte NADPH
oxidase. Histochem Cell Biol 122: 277–291.
Netea, M.G., Brown, G.D., Kullberg, B.J., and Gow, N.A.
(2008) An integrated model of the recognition of Candida
albicans by the innate immune system. Nat Rev Microbiol
6: 67–78.
Noble, S.M., and Johnson, A.D. (2005) Strains and strategies
for large-scale gene deletion studies of the diploid human
fungal pathogen Candida albicans. Eukaryot Cell 4: 298–
309.
Pfaller, M.A., and Diekema, D.J. (2007) Epidemiology of inva-
sive candidiasis: a persistent public health problem. Clin
Microbiol Rev 20: 133–163.
Piddington, D.L., Fang, F.C., Laessig, T., Cooper, A.M.,
Orme, I.M., and Buchmeier, N.A. (2001) Cu, Zn superoxide
dismutase of Mycobacterium tuberculosis contributes to
survival in activated macrophages that are generating an
oxidative burst. Infect Immun 69: 4980–4987.
Ramirez-Zavala, B., Reuss, O., Park, Y.N., Ohlsen, K., and
Morschhauser, J. (2008) Environmental induction of white-
opaque switching in Candida albicans. PLoS Pathog 4:
e1000089.
Reuss, O., Vik, A., Kolter, R., and Morschhauser, J. (2004)
The SAT1 ﬂipper, an optimized tool for gene disruption in
Candida albicans. Gene 341: 119–127.
Richard, M.L., and Plaine, A. (2007) Comprehensive analysis
of glycosylphosphatidylinositol-anchored proteins in
Candida albicans. Eukaryot Cell 6: 119–133.
Rocha, C.R., Schroppel, K., Harcus, D., Marcil, A., Dignard,
D., Taylor, B.N., et al. (2001) Signaling through adenylyl
cyclase is essential for hyphal growth and virulence in the
pathogenic fungus Candida albicans. Mol Biol Cell 12:
3631–3643.
Romani, L. (2004) Immunity to fungal infections. Nat Rev
Immunol 4: 1–13.
Rubin-Bejerano, I., Abeijon, C., Magnelli, P., Grisaﬁ, P., and
Fink, G.R. (2007) Phagocytosis by human neutrophils is
stimulated by a unique fungal cell wall component. Cell
Host Microbe 2: 55–67.
Savina, A., Jancic, C., Hugues, S., Guermonprez, P., Vargas,
P., Moura, I.C., et al. (2006) NOX2 controls phagosomal
pH to regulate antigen processing during crosspresenta-
tion by dendritic cells. Cell 126: 205–218.
Schrenzel, J., Serrander, L., Banﬁ, B., Nusse, O., Fouyouzi,
R., Lew, D.P., et al. (1998) Electron currents generated by
the human phagocyte NADPH oxidase. Nature 392: 734–
737.
Stockinger, S., Materna, T., Stoiber, D., Bayr, L., Steinborn,
R., Kolbe, T., et al. (2002) Production of type I IFN
sensitizes macrophages to cell death induced by Listeria
monocytogenes. J Immunol 169: 6522–6529.
Taylor, P.R. (2007) Dectin-1 is required for [beta]-glucan rec-
ognition and control of fungal infection. Nat Immunol 8:
31–38.
Teixeira, H.D., Schumacher, R.I., and Meneghini, R. (1998)
Lower intracellular hydrogen peroxide levels in cells over-
expressing CuZn-superoxide dismutase. Proc Natl Acad
Sci USA 95: 7872–7875.
Watanabe, K., Kagaya, K., Yamada, T., and Fukazawa, Y.
(1991) Mechanism for candidacidal activity in macro-
phages activated by recombinant gamma interferon.
Infect Immun 59: 521–528.
Yeung, T., Touret, N., and Grinstein, S. (2005) Quantitative
ﬂuorescence microscopy to probe intracellular micro-
environments. Curr Opin Microbiol 8: 350–358.
Supporting information
Additional supporting information may be found in the online
version of this article.
Please note: Wiley-Blackwell are not responsible for the
content or functionality of any supporting materials supplied
by the authors. Any queries (other than missing material)
should be directed to the corresponding author for the
article.
252 I. E. Frohner etal. 
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 71, 240–252